The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park Comprehensive Cancer Center, as a possible treatment for pancreatic ...
Feb 5, 2024
0
0
A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to new research. The results of the studies indicate that the ...
Jan 11, 2024
0
0
Exposure to Agent Orange is associated with a small but significantly increased risk of bladder cancer among male Vietnam veterans, according to a study published online June 27 in JAMA Network Open.
Jun 29, 2023
0
2
Not everyone reacts to infectious agents in the same way: some fall ill very severely, others only slightly, and still others possibly not at all.
Jun 12, 2023
0
27
Research conducted at Georgetown University's Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing ...
Jun 2, 2023
0
9
A new research paper was published in Oncotarget, titled, "Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines."
Mar 28, 2023
0
5
Inspired by the foam on top of lattes, as well as gummy bears and Pop Rocks candies, researchers at the University of Iowa are creating new, biocompatible materials that may improve the effectiveness of chemotherapy and radiation ...
Feb 2, 2023
0
33
The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue and glows when stimulated by ...
Dec 17, 2022
0
5
For people waiting for imaging tests to diagnose neuroendocrine cancer, time is of the essence. Now, thanks to researchers at the University of Alberta, a new medical imaging agent for PET scans promises to reduce wait times, ...
Nov 30, 2022
0
3
A new molecular imaging radiotracer can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies. In the largest medical study of its kind, researchers ...
Nov 17, 2022
0
49
